Multiple randomized controlled trials have demonstrated that administration of recombinant tissue plasminogen activator (rt-PA) within 4.5 h of stroke onset significantly improves the likelihood of a favorable prognosis, regardless of age or stroke severity2. The gene discussed is PLAT; the disease is stroke disorder.